6
Participants
Start Date
January 8, 2025
Primary Completion Date
July 30, 2025
Study Completion Date
December 15, 2025
Blinatumomab
IV infusion
Akita University Hospital, Akita
Kyushu University Hospital, Fukuoka
Kurume University Hospital, Kurume-shi
Fukushima Medical University Hospital, Fukushima
Kanazawa University Hospital, Kanazawa
Yamagata University Hospital, Yamagata
Lead Sponsor
Amgen
INDUSTRY